代谢物α-酮戊二酸部分通过调控TET2/NLRP3炎症小体信号通路抑制血管钙化
在慢性肾脏病(CKD)中血管钙化普遍存在,现有治疗效果不佳。本研究在大鼠和小鼠CKD模型及人血管平滑肌细胞中发现,α-酮戊二酸(AKG)可改善血管钙化,机制部分通过上调TET2并抑制NLRP3炎症小体。
要点
- AKG改善CKD大鼠和小鼠的主动脉钙化及大鼠和人动脉环钙化。
- AKG上调DNA去甲基化酶TET2,TET2缺失或抑制加重血管钙化。
- TET2过表达减轻钙化,TET2敲除减弱AKG的抑制作用。
核心结论
- AKG部分通过上调TET2和抑制NLRP3炎症小体减轻血管钙化,表观遗传修饰因子在血管钙化中起关键作用。
- 调控TET2可能成为治疗血管钙化的有前景策略。
研究设计与样本
- 在体内和体外骨诱导条件下,用AKG处理啮齿动物和人血管平滑肌细胞(VSMCs)研究矿物质沉积。
- 使用大鼠和小鼠CKD模型、大鼠主动脉环及人动脉环进行离体实验。
主要发现
- AKG治疗显著改善大鼠和人动脉环离体钙化及CKD大鼠和小鼠主动脉钙化。
- AKG上调血管钙化过程中DNA去甲基化酶TET2表达。
- siRNA敲低TET2或Bobcat339药理学抑制TET2促进大鼠VSMCs钙化,Bobcat339还增强大鼠主动脉环钙化。
- TET2过表达改善大鼠VSMCs、大鼠主动脉环和CKD大鼠的血管钙化。
- VSMC特异性TET2缺陷促进CKD小鼠主动脉钙化。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Vascular calcification is prevalent in chronic kidney disease (CKD), but existing medical treatments fail to achieve satisfactory therapeutic effects. Vascular calcification is now recognized as an active multifactorial process involving diverse mechanisms. Alpha-ketoglutarate (AKG), an intermediate in tricarboxylic acid cycle, has been demonstrated to extend lifespan and ameliorate age-related osteoporosis. However, whether AKG inhibits vascular calcification remains unknown. METHODS: Here, mineral deposition was studied with AKG treatment in rodent and human vascular smooth muscle cells (VSMCs) under osteogenic conditions in vivo and in vitro. RESULTS: AKG treatment remarkably ameliorated calcification of rat and human arterial rings ex vivo and aortic calcification in CKD rats and mice. Mechanistically, AKG treatment upregulated DNA demethylase ten-eleven translocation 2 (TET2) expression during vascular calcification. Knockdown of TET2 by siRNA and pharmacological inhibition of TET2 by Bobcat339 promoted vascular calcification in rat VSMCs. Bobcat339 also enhanced rat aortic ring calcification. Conversely, TET2 overexpression ameliorated vascular calcification in rat VSMCs, rat aortic rings and CKD rats. Furthermore, VSMC-specific TET2 deficiency promoted aortic calcification in CKD mice. Both TET2 siRNA and Bobcat339 independently counteracted the inhibitory effect of AKG on vascular calcification of rat VSMCs. Inhibitory effect of AKG administration on vascular calcification was reduced in TET2 knockout mice. TET2 overexpression reduced the levels of the NLRP3 inflammasome pathway, cleaved Caspase-1 and IL-1β protein expression in VSMCs and NLRP3 agonist Nigericin-induced cell calcification. CONCLUSIONS: Our study demonstrate that AKG attenuates vascular calcification partially via upregulation of TET2 and inhibition of NLRP3 inflammasome, indicating the critical role of epigenetic modifier in vascular calcification. Modulation of TET2 may become a promising strategy for the treatment of vascular calcification.
引用
- Fu M, Lan Z, Ye Y, et al. The metabolite alpha-ketoglutarate inhibits vascular calcification partially through modulation of the TET2/NLRP3 inflammasome signaling pathway. Kidney Int. 2025. PMID: 40383231. doi:10.1016/j.kint.2025.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。